Trump's New Executive Order: Can It Finally Lower Prescription Drug Costs?

President Trump's new executive order aims at lowering the cost of prescription drugs. This is a reprise of a similar initiative that failed during his first term. The plan faces significant hurdles, including potential lawsuits and resistance from the pharmaceutical industry. According to the video, the US pays nearly three times more for prescription drugs than other high-income countries. One expert noted, "It's going to be contested in the federal courts again, which is how it failed last time." The high cost is partly attributed to the pharmaceutical industry's substantial lobbying efforts in Washington, D.C. The video also highlights the fragmented US healthcare system, lacking a unified negotiator for drug prices. Significant reform is needed to address campaign finance reform and the way drug prices are negotiated. The executive order presents a fresh attempt to tackle this long-standing issue, but its success remains uncertain given the formidable obstacles.